INVO Bioscience CEO Steven Shum receives $1.3M in 2019

INVO Bioscience reports 2019 executive compensation

By ExecPay News

Published: November 20, 2020

INVO Bioscience reported fiscal year 2019 executive compensation information on November 20, 2020.
In 2019, six executives at INVO Bioscience received on average a compensation package of $458.9K, a 99% increase compared to previous year.
Average pay of disclosed executives at INVO Bioscience
Steven Shum, Chief Executive Officer, received $1.3M in total. 93.25% of Shum's compensation, or $1.3M, was in option awards. Shum also received $73.2K in salary and $17.8K in stock awards.
Kathleen Karloff, Chief Executive Officer, received a compensation package of $526.8K, which increased by 339% compared to previous year. 66.78% of the compensation package, or $351.8K, was in option awards.
Robert Bowdring, Chief Financial Officer, earned $365.9K in 2019, a 205% increase compared to previous year.
Michael Campbell, Chief Operating Officer, received $258.9K in 2019.
Lori Marzilli-Kahler, Former VP, Global Operations, earned $185K in 2019, a 66% decrease compared to previous year.
Debra Hoopes, Chief Financial Officer, received $69.8K in 2019.

Related executives

Kathleen Karloff

INVO Bioscience

Chief Executive Officer

Steven Shum

INVO Bioscience

Chief Executive Officer

Michael Campbell

INVO Bioscience

Chief Operating Officer

Lori Marzilli-Kahler

INVO Bioscience

Former VP, Global Operations

Robert Bowdring

INVO Bioscience

Chief Financial Officer

Debra Hoopes

INVO Bioscience

Chief Financial Officer

You may also like

Source: SEC filing on November 20, 2020.